Clin2
NCT07447050Likely a fitRecruiting

Riluzole to Prevent Chemo-Related Cognitive Problems

Breast CancerSarcomaGastric (Stomach) CancerLung CancerHead and Neck CancerColorectal CancerOvarian CancerLiver Cancer

Treatments studied

Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.

This pilot study tests whether the drug riluzole can help prevent the thinking and memory problems (often called 'chemobrain') that some people experience during chemotherapy. If you are about to start a chemo regimen containing an anthracycline or platinum drug, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
24 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have a cancer diagnosis and be scheduled for chemotherapy that includes an anthracycline or platinum drug (like doxorubicin or cisplatin).
  • You must be at least 18 years old and have a life expectancy of more than 6 months.
  • You agree to complete surveys and computer tests to measure thinking and memory (if you have vision problems or a condition like Parkinson's, you can still join as long as you can do the surveys with help).
  • You cannot have a primary brain tumor or cancer that has spread to your brain.
  • You cannot have liver problems (based on blood tests).
  • You cannot be a current smoker, or be taking certain medications that could interact with riluzole (such as cannabis, certain cancer drugs, methotrexate, etc.), and if you are female and able to get pregnant, you must not be pregnant or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06580002Recruiting· Phase 2
Can Riluzole Help with Chemo Brain? A Pilot Study

This study tests if a medicine called riluzole (currently used for ALS) can help with 'chemo brain' – memory and thinking problems after cancer treatment. It is for people who feel their mental sharpness has declined after breast cancer therapy, certain chemotherapies, or brain radiation.

Orange, California
NCT04520139Recruiting· Phase 1/Phase 2
NAC to help prevent chemo brain fog in ovarian cancer

This Phase 1/2 study tests whether taking NAC (a supplement medicine) can help prevent or reduce memory and thinking problems after platinum chemotherapy. It targets people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are starting at least six cycles of platinum-based treatment.

Orange, California
NCT07465497Enrolling by invitation
Preventing Chemo Brain with Prebiotics and Synbiotics

This trial tests whether taking a special blend of prebiotics and synbiotics (friendly bacteria and food for them) can help prevent or reduce memory and thinking problems that sometimes happen during chemotherapy for breast cancer.

Zapopan, Jalisco
NCT07372144Not yet recruiting· Phase 3
Creatine for brain health during breast cancer chemo

This study tests whether taking creatine (a natural supplement) during and after chemotherapy can help protect your memory and thinking skills in women with early-stage breast cancer. You would receive either creatine or a placebo pill and be followed with cognitive tests.

São Paulo, São Paulo
NCT02290834Recruiting
Studying brain and thinking changes after chemotherapy in older breast cancer patients

This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.

Boston, Massachusetts
NCT05305092Recruiting
Study of memory and thinking in early breast cancer

This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.

Xi'an, Shaanxi

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.